BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30035295)

  • 1. Diagnostic Value of Glucose Transporter 1 (GLUT-1) Expression in Nested Variant of Urothelial Carcinoma.
    Boyaci C; Behzatoğlu K
    Turk Patoloji Derg; 2019; 35(1):22-27. PubMed ID: 30035295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Florid von Brunn nests mimicking urothelial carcinoma: a morphologic and immunohistochemical comparison to the nested variant of urothelial carcinoma.
    Volmar KE; Chan TY; De Marzo AM; Epstein JI
    Am J Surg Pathol; 2003 Sep; 27(9):1243-52. PubMed ID: 12960809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose transporter-1 expression in urothelial papilloma of the bladder.
    Lee JH; Kim YW; Chang SG
    Urol Int; 2005; 74(3):268-71. PubMed ID: 15812216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nested variant of urothelial carcinoma.
    Dhall D; Al-Ahmadie H; Olgac S
    Arch Pathol Lab Med; 2007 Nov; 131(11):1725-7. PubMed ID: 17979494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large nested variant of urothelial carcinoma: 23 cases mimicking von Brunn nests and inverted growth pattern of noninvasive papillary urothelial carcinoma.
    Cox R; Epstein JI
    Am J Surg Pathol; 2011 Sep; 35(9):1337-42. PubMed ID: 21836490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Epidermal Growth Factor Receptor 2 Overexpression in Micropapillary and Other Variants of Urothelial Carcinoma.
    Behzatoğlu K; Yörükoğlu K; Demir H; Bal N
    Eur Urol Focus; 2018 Apr; 4(3):399-404. PubMed ID: 28753766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Urothelial hyperplastic lesion with endophytic growth pattern: a clinicopathologic study].
    Xiao L; Wang CF; Zhu XZ; Yin YL; Chen Y; Lu C; Yu B
    Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):319-23. PubMed ID: 21756826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathological and immunohistochemical study of papillary urothelial neoplasms of low malignant potential and grade associated with extensive invasive low-grade urothelial carcinoma.
    Mai KT; Elmontaser G; Perkins DG; Yazdi HM; Stinson WA; Thijssen A
    BJU Int; 2004 Sep; 94(4):544-7. PubMed ID: 15329109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of cytokeratin 5/6, cytokeratin 20, and p16 in the diagnosis of reactive urothelial atypia and noninvasive component of urothelial neoplasia.
    Edgecombe A; Nguyen BN; Djordjevic B; Belanger EC; Mai KT
    Appl Immunohistochem Mol Morphol; 2012 May; 20(3):264-71. PubMed ID: 22498670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of ProEx C in the histologic evaluation of the neoplastic and nonneoplastic urothelial lesions.
    Moatamed NA; Vergara-Lluri ME; Lu D; Apple SK; Kerkoutian S; Rao JY
    Hum Pathol; 2013 Nov; 44(11):2509-17. PubMed ID: 24029711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinguishing nested variants of urothelial carcinoma from benign mimickers by TERT promoter mutation.
    Zhong M; Tian W; Zhuge J; Zheng X; Huang T; Cai D; Zhang D; Yang XJ; Argani P; Fallon JT; Epstein JI
    Am J Surg Pathol; 2015 Jan; 39(1):127-31. PubMed ID: 25118812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nested variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of 30 pure and mixed cases.
    Wasco MJ; Daignault S; Bradley D; Shah RB
    Hum Pathol; 2010 Feb; 41(2):163-71. PubMed ID: 19800100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inverted variant of urothelial carcinoma of the urinary bladder: a report of three cases and a proposal for a new clinicopathologic entity.
    Terada T
    Int J Clin Exp Pathol; 2013; 6(4):766-70. PubMed ID: 23573325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The spectrum of histopathologic findings in vesical diverticulum: implications for pathogenesis and staging.
    Idrees MT; Alexander RE; Kum JB; Cheng L
    Hum Pathol; 2013 Jul; 44(7):1223-32. PubMed ID: 23375647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive urothelial carcinoma exhibiting basal cell immunohistochemical markers: A variant of urothelial carcinoma associated with aggressive features.
    Mai KT; Truong LD; Ball CG; Williams P; Flood TA; Belanger EC
    Pathol Res Pract; 2015 Aug; 211(8):610-8. PubMed ID: 26100813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urothelial carcinoma (clear cell variant) diagnosed with useful immunohistochemistry stain.
    Yamashita R; Yamaguchi R; Yuen K; Niwakawa M; Tobisu K
    Int J Urol; 2006 Nov; 13(11):1448-50. PubMed ID: 17083402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAX8 positivity in nested variant of urothelial carcinoma: a potential diagnostic pitfall.
    Legesse T; Matoso A; Epstein JI
    Hum Pathol; 2019 Dec; 94():11-15. PubMed ID: 31669177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of caveolin-1 and caveolin-2 in urothelial carcinoma of the urinary bladder correlates with tumor grade and squamous differentiation.
    Fong A; Garcia E; Gwynn L; Lisanti MP; Fazzari MJ; Li M
    Am J Clin Pathol; 2003 Jul; 120(1):93-100. PubMed ID: 12866378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IMP3 predicts aggressive superficial urothelial carcinoma of the bladder.
    Sitnikova L; Mendese G; Liu Q; Woda BA; Lu D; Dresser K; Mohanty S; Rock KL; Jiang Z
    Clin Cancer Res; 2008 Mar; 14(6):1701-6. PubMed ID: 18347170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nested variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of 12 cases.
    Lin O; Cardillo M; Dalbagni G; Linkov I; Hutchinson B; Reuter VE
    Mod Pathol; 2003 Dec; 16(12):1289-98. PubMed ID: 14681330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.